Discover Biomedica´s bone biomarker assays
Biomedica´s bone biomarker assays have been designed to provide accurate and reproducible results for clinical and preclinical research.
Trusted and widely cited ELISA assays for biomarkers in bone metabolism, cardiovascular and renal diseases, cancer and oxidative stress.
Biomedica has over 30 years of experience in developing and manufacturing ELISA kits following high level international quality standards.
With their pre-clinical and clinical immunoassays, they provide scientists and healthcare professionals with tests that enable discoveries, support the translation of research into diagnostics, and, in the case of CE marked products, assist in the diagnosis of pathologies.
WNT INHIBITORS | Sclerostin, Bioactive Sclerostin, Dickkopf-1 (DKK-1) |
BONE METABOLISM | Osteoprotegerin (OPG), soluble RANKL (sRANKL), Semaphorin 4D |
NEPHROLOGY | FGF23 (C-term), FGF23 (intact), Endostatin, Vanin-1 (human, mouse and rat), Neuropilin-1, anti-C4d antibody |
NATRIURETIC PEPTIDES | NT-proBNP (human – CE), NT-proBNP (rat), NT-proANP (human and rat), NT-proCNP (human) |
ENDOTHELINS | Big Endothelin-1 |
CYTOKINES | IL-6 (human), VEGF (human) , Angiopoietin-2 (human, mouse/rat) |
OXIDATIVE STRESS | oLAB (Anti-oxidized LDL auto antibodies), OxyStat (biological Peroxides) |
OTHER | LRG, EZ4U Cell Proliferation & Cytotoxicity Assay |
Understanding the importance of high quality, they offer fully validated ELISA kits for your research. Biomedica kits are optimized for reliability, sensitivity, precision, and ease-of-use.
ELISA kit Validation
All Biomedica immunoassays are validated for multiple sample matrices according to international quality guidelines. Their validation experiments include:
Accuracy – Dilution Linearity and Parallelism – Specificity – Cross-reactivity
Sensitivity – Precision – Calibration – Stability
ELISA Quality Management
Biomedica assays undergo a stringent quality control process, ensuring lot-to lot consistency with a panel of quality control samples being an integral part of the manufacturing protocols. The QC panels consist of samples from different matrices (e.g. serum, EDTA-plasma, citrate-plasma) containing the endogenous/natural analyte as well as samples spiked with the recombinant protein. Every new lot as well as all retains, that are assayed every three months, are tested with this specific QC sample panel.
Biomedica´s manufacturing process follows the ISO 9001: 2015 management system and conforms to GMP / GLP guidelines.
Analytical Service Measurements
We gladly support you by keeping you updated on our latest products and the developments around our services.